|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12N 15/11 | (2006.01) |
| C12N 15/113 | (2010.01) |
| (11) | Number of the document | 2302055 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10183577.5 |
| Date of filing the European patent application | 2005-11-14 | |
| (97) | Date of publication of the European application | 2011-03-30 |
| (45) | Date of publication and mention of the grant of the patent | 2014-08-27 |
| (46) | Date of publication of the claims translation | 2015-01-26 |
| (30) | Number | Date | Country code |
| 627171 P | 2004-11-12 | US | |
| 649634 P | 2005-02-03 | US | |
| 683736 P | 2005-05-23 | US |
| (72) |
Brown, David, US
Ford, Lance, US
Cheng, Angie, US
Jarvis, Rich, US
Byrom, Mike, US
Ovcharenko, Dmitriy, US
Devroe, Eric, US
Kelnar, Kevin, US
|
| (73) |
Asuragen, Inc.,
2150 Woodward St Suite 100, Austin TX 78744,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Būdai ir kompozicijos, susiję su miRNR ir miRNR inhibitorinėmis molekulėmis |
| Methods and compositions involving miRNA and miRNA inhibitor molecules |
| Payment date | Validity (years) | Amount | |
| 2015-11-18 | 11 | 433.50 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2016-11-14 |